Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | USP1 | O94782 | 9/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | TRPC5 | Q9UL62 | 2/20 | 0.32 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31566299 | 0.85 | DYRK1A (0.37) | USP1TRPA1DPP4TRPC5GRM5 | |
| SCHEMBL31566306 | 0.82 | IKBKB (0.35) | USP1MEN1KMT2ATRPA1DPP4 | |
| SCHEMBL31566327 | 0.81 | USP1 (0.34) | USP1TRPA1DPP4TRPC5GRM5 | |
| SCHEMBL31566328 | 0.79 | TSHR (0.41) | USP1DPP4TRPC5GRM5PIP4K2C | |
| SCHEMBL31566321 | 0.78 | CDK1 (0.48) | USP1 | |
| SCHEMBL31566310 | 0.78 | DDB1 (0.37) | MEN1KMT2ADPP4SOS1GRM5 | |
| SCHEMBL31566330 | 0.77 | USP1 (0.34) | USP1KMT2ADPP4GRM5 | |
| SCHEMBL31566332 | 0.75 | MEN1 (0.34) | USP1MEN1KMT2A | |
| SCHEMBL24402001 | 0.73 | CDK1 (0.36) | LMNAMEN1KMT2A | |
| SCHEMBL31566301 | 0.71 | ATR (0.36) | LMNAUSP1DPP4PIP4K2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096505-A1 | UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-05-08 | — | — | WO | disclosed |